AM Squared’s ResMed RMD Stock Holding History

AM Squared’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-300	Closed	-$57.4K	–	91
2024 Q2	$57.4K	Sell	300 -200	-40%	-$40.6K	0.15%	54
2024 Q1	$99K	Buy	+500	New	+$91.6K	0.24%	15

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

AM Squared's RMD Position: Q3 2024 in Review

AM Squared sold out of ResMed (RMD) in Q3 2024, closing a stake of 300 shares — an estimated $57.4K sold.

AM Squared first reported a position in RMD in Q1 2024 and held it in 2 quarters. The position peaked at $99K in Q1 2024. 802 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

AM Squared reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
AM Squared sold 300 ResMed shares in Q3 2024, an estimated $57.4K.
AM Squared first reported a position in ResMed in Q1 2024 and held it in 2 quarters.
AM Squared's ResMed position peaked at $99K in Q1 2024.
802 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.